Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-19

Clinical Trial Update: Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine to bupivacaine with dexmedetomidine for erector spinae plane blocks in mastectomy patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine + Dexmedetomidine (bupivacaine with dexmedetomidine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: United States Naval Medical Center, Portsmouth | Conditions: Breast Cancer | Phase 4 | Status: RECRUITING